| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |